Limits...
Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis.

Lee SJ, Kang JH, Kim JY, Kim JH, Yoon SR, Jung KI - Ann Rehabil Med (2013)

Bottom Line: Significant VAS and RM score improvement, and PF thickness reduction were observed in both groups (p<0.01).After 3 sessions of ESWT, group M showed significant improvement in the VAS and RM score than group L, whereas after 3 additional sessions applied in group L, the main outcomes were no longer significantly different in both groups (p>0.05).Therapeutic effect might disclose a dose-related relationship; therefore, EFD and the times of the session are considerable factors when treating with ESWT.

View Article: PubMed Central - PubMed

Affiliation: Department of Rehabilitation Medicine, Gwangju Veterans Hospital, Gwangju, Korea.

ABSTRACT

Objective: To examine the dose-related effect of extracorporeal shock wave therapy (ESWT) for plantar fasciitis.

Methods: Sixty patients with plantar fasciitis despite conservative treatment were enrolled. The patients were divided into a low-energy group (group L: n=30, 1,000 shocks/session, energy flux density [EFD] per shock 0.08 mJ/mm(2)) and a medium-energy group (group M: n=30, 1,000 shocks/session, EFD 0.16 mJ/mm(2)). The main outcome measures were visual analogue scale (VAS), Roles and Maudsley (RM) score, and thickness of plantar fascia (PF). To compare the effects between each group, follow-up was carried out 1 week after 3 and 6 sessions, and 1 and 3 months after ESWT.

Results: Significant VAS and RM score improvement, and PF thickness reduction were observed in both groups (p<0.01). After 3 sessions of ESWT, group M showed significant improvement in the VAS and RM score than group L, whereas after 3 additional sessions applied in group L, the main outcomes were no longer significantly different in both groups (p>0.05).

Conclusion: Therapeutic effect might disclose a dose-related relationship; therefore, EFD and the times of the session are considerable factors when treating with ESWT.

No MeSH data available.


Related in: MedlinePlus

Temporal changes of pain (mean±standard deviation) at 0 and 1 week and at 1-3 month follow-up after extracorporeal shock wave therapy (ESWT) in the same total energy influx groups (groups M3 and L6). Group M3, 3 sessions of medium-energy (0.16 mJ/mm2) in ESWT group; group L6, 6 session of low-energy (0.08 mJ/mm2) ESWT group; VAS (U), visual analogue scale at usual time; VAS (F), visual analogue scale at first step in the morning; VAS (C), visual analogue scale of compression at calcaneus; VAS (S), visual analogue scale at sleeping. No significant difference was observed between both groups in VAS (U), p=0.717; VAS (F), p=0.778; VAS (C), p=0.829; and VAS (S), p=0.998. a)p<0.001 significantly different vs. 0 week within group M3. b)p<0.001 significantly different vs. 0 week within group L6.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3713295&req=5

Figure 3: Temporal changes of pain (mean±standard deviation) at 0 and 1 week and at 1-3 month follow-up after extracorporeal shock wave therapy (ESWT) in the same total energy influx groups (groups M3 and L6). Group M3, 3 sessions of medium-energy (0.16 mJ/mm2) in ESWT group; group L6, 6 session of low-energy (0.08 mJ/mm2) ESWT group; VAS (U), visual analogue scale at usual time; VAS (F), visual analogue scale at first step in the morning; VAS (C), visual analogue scale of compression at calcaneus; VAS (S), visual analogue scale at sleeping. No significant difference was observed between both groups in VAS (U), p=0.717; VAS (F), p=0.778; VAS (C), p=0.829; and VAS (S), p=0.998. a)p<0.001 significantly different vs. 0 week within group M3. b)p<0.001 significantly different vs. 0 week within group L6.

Mentions: Group M3 experienced a larger pain reduction effect compared to group L3 (Table 4). In groups L6 and M3, across all scores (average VAS score during daily activities, sleep, during manual compression, and taking the first steps in the morning) statistically significant improvements were exhibited over time (p<0.001); however, the pain scores did not differ significantly between the two groups (p>0.05) (Fig. 3).


Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis.

Lee SJ, Kang JH, Kim JY, Kim JH, Yoon SR, Jung KI - Ann Rehabil Med (2013)

Temporal changes of pain (mean±standard deviation) at 0 and 1 week and at 1-3 month follow-up after extracorporeal shock wave therapy (ESWT) in the same total energy influx groups (groups M3 and L6). Group M3, 3 sessions of medium-energy (0.16 mJ/mm2) in ESWT group; group L6, 6 session of low-energy (0.08 mJ/mm2) ESWT group; VAS (U), visual analogue scale at usual time; VAS (F), visual analogue scale at first step in the morning; VAS (C), visual analogue scale of compression at calcaneus; VAS (S), visual analogue scale at sleeping. No significant difference was observed between both groups in VAS (U), p=0.717; VAS (F), p=0.778; VAS (C), p=0.829; and VAS (S), p=0.998. a)p<0.001 significantly different vs. 0 week within group M3. b)p<0.001 significantly different vs. 0 week within group L6.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3713295&req=5

Figure 3: Temporal changes of pain (mean±standard deviation) at 0 and 1 week and at 1-3 month follow-up after extracorporeal shock wave therapy (ESWT) in the same total energy influx groups (groups M3 and L6). Group M3, 3 sessions of medium-energy (0.16 mJ/mm2) in ESWT group; group L6, 6 session of low-energy (0.08 mJ/mm2) ESWT group; VAS (U), visual analogue scale at usual time; VAS (F), visual analogue scale at first step in the morning; VAS (C), visual analogue scale of compression at calcaneus; VAS (S), visual analogue scale at sleeping. No significant difference was observed between both groups in VAS (U), p=0.717; VAS (F), p=0.778; VAS (C), p=0.829; and VAS (S), p=0.998. a)p<0.001 significantly different vs. 0 week within group M3. b)p<0.001 significantly different vs. 0 week within group L6.
Mentions: Group M3 experienced a larger pain reduction effect compared to group L3 (Table 4). In groups L6 and M3, across all scores (average VAS score during daily activities, sleep, during manual compression, and taking the first steps in the morning) statistically significant improvements were exhibited over time (p<0.001); however, the pain scores did not differ significantly between the two groups (p>0.05) (Fig. 3).

Bottom Line: Significant VAS and RM score improvement, and PF thickness reduction were observed in both groups (p<0.01).After 3 sessions of ESWT, group M showed significant improvement in the VAS and RM score than group L, whereas after 3 additional sessions applied in group L, the main outcomes were no longer significantly different in both groups (p>0.05).Therapeutic effect might disclose a dose-related relationship; therefore, EFD and the times of the session are considerable factors when treating with ESWT.

View Article: PubMed Central - PubMed

Affiliation: Department of Rehabilitation Medicine, Gwangju Veterans Hospital, Gwangju, Korea.

ABSTRACT

Objective: To examine the dose-related effect of extracorporeal shock wave therapy (ESWT) for plantar fasciitis.

Methods: Sixty patients with plantar fasciitis despite conservative treatment were enrolled. The patients were divided into a low-energy group (group L: n=30, 1,000 shocks/session, energy flux density [EFD] per shock 0.08 mJ/mm(2)) and a medium-energy group (group M: n=30, 1,000 shocks/session, EFD 0.16 mJ/mm(2)). The main outcome measures were visual analogue scale (VAS), Roles and Maudsley (RM) score, and thickness of plantar fascia (PF). To compare the effects between each group, follow-up was carried out 1 week after 3 and 6 sessions, and 1 and 3 months after ESWT.

Results: Significant VAS and RM score improvement, and PF thickness reduction were observed in both groups (p<0.01). After 3 sessions of ESWT, group M showed significant improvement in the VAS and RM score than group L, whereas after 3 additional sessions applied in group L, the main outcomes were no longer significantly different in both groups (p>0.05).

Conclusion: Therapeutic effect might disclose a dose-related relationship; therefore, EFD and the times of the session are considerable factors when treating with ESWT.

No MeSH data available.


Related in: MedlinePlus